A LEADER IN FIRST-IN-PATIENT STUDIES
Phase 1 Clinical Trials
The MEU is a UK leader in First in Man studies. We have considerable expertise in SAD and MAD trials. The emergence of hybrid designs, including patient cohorts, has allowed the MEU to provide a complete solution for clients seeking a single site solution for their Phase 1 programme.
The MEU is well-equipped to undertake large single centre early phase healthy volunteer clinical trials and specialist respiratory trials including Asthma, COPD, Cystic Fibrosis, Allergy, Dermatology, Inflammatory, Cardiovascular and Diabetes. Our ever-expansive portfolio facilitates the MEU to undertake Phase 1 studies in many other therapeutic areas.
State-of-the-art, hospital-based facilities including 36 inpatient beds with cardiac and telemetry monitoring, a pharmacy, clinical assessment suite, bronchoscopy unit and numerous outpatient/consultant rooms.
Contact us today to sense-check your protocol synopsis against our ICARUS phenotyped database of over 17,000 clinical trial volunteers. We can run inclusion/exclusion criteria in minutes, instantly checking the phenotyped data across multiple therapeutic fields.
A leader in First-In-Patient studies for over twenty years
- Posted by The MEU
- On 21st November 2018
Coinciding with World COPD Day 2018, The GOLD recommendations for the management of Chronic Obstructive Pulmonary Disease (COPD) have been re-written and...